Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bilibili Inc. - American Depositary Shares | 71BA | Nov 14, 2024 | 19.90 | -0.50 |
Bill.com Holdings, Inc. | 0M5 | Nov 14, 2024 | 82.83 | -1.13 |
BillerudKorsnäs | BNF | Nov 14, 2024 | 8.53 | +0.83 |
BIMobject | BOJB | Nov 14, 2024 | 0.35 | -1.12 |
Binah Capital Group | O1Y | Nov 14, 2024 | 3.12 | -5.45 |
Binect AG | MA10 | Nov 14, 2024 | 1.88 | -3.59 |
Binhai Investment Co Ltd | WS7A | Nov 14, 2024 | 0.12 | 0.00 |
Bio Planet SA | 8WS | Nov 14, 2024 | 3.32 | 0.00 |
Bio-Gate AG | BIG1 | Nov 14, 2024 | 0.68 | 0.00 |
Bio-Rad Laboratories, Inc. Class A | BUWA | Nov 14, 2024 | 340.40 | +0.29 |
Bio-Techne Corp | TE1 | Nov 14, 2024 | 68.50 | -4.86 |
Bio-Uv Group | 4Y4 | Nov 14, 2024 | 1.77 | -0.45 |
Bio-Works Technologies | 1BD | Nov 14, 2024 | 0.05 | -10.42 |
BioArctic B | B9A | Nov 14, 2024 | 12.96 | +7.55 |
BioCardia, Inc. | 6JU | Nov 14, 2024 | 4.26 | 0.00 |
BIOCELTIX S.A. | XI3 | Nov 14, 2024 | 15.06 | -2.84 |
BioCryst Pharmaceuticals, Inc. | BO1 | Nov 14, 2024 | 7.19 | -3.41 |
Biocure Technology | 1WH0 | Nov 14, 2024 | 0.03 | 0.00 |
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. | I54 | Nov 14, 2024 | 0.81 | +31.97 |
Bioera S.P.A | B2A | Nov 14, 2024 | 0.05 | +6.61 |
Bioextrax | 85X0 | Nov 14, 2024 | 0.28 | +0.37 |
BioFish Holding AS | 9R2 | Nov 14, 2024 | 0.05 | +5.17 |
Biofrontera AG | B8FK | Nov 14, 2024 | 2.90 | +8.41 |
BIOGAIA AB B O.N. | BGLA | Nov 14, 2024 | 9.01 | 0.00 |
Biogen Inc. | IDP | Nov 14, 2024 | 158.10 | +0.06 |
BioHarvest Sciences | 8MV0 | Nov 14, 2024 | 5.10 | +0.39 |
BioInvent International | BIX0 | Nov 14, 2024 | 4.21 | +3.06 |
BioLife Solutions, Inc. | BJX1 | Nov 14, 2024 | 22.60 | -8.87 |
BioLineRx Ltd. - American Depositary Shares | YP2A | Nov 14, 2024 | 0.38 | +1.06 |
BioMarin Pharmaceutical Inc. | BM8 | Nov 14, 2024 | 62.78 | +0.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.